Physician profile
Michael Savin
NPI 1821059049
$69,217.55
in general payments reported to CMS, 2019-2025
11 companies · $6,029 in 2025
The $6,029 reported for 2025 was more than what 87% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $79.21 · 2022: $11K · 2023: $42K · 2024: $9,397 · 2025: $6,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Long Term Medical Supply Or Device Loan: $13K · Travel and Lodging: $2,912 · Food and Beverage: $2,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,112.50 |
| Long Term Medical Supply Or Device Loan | $12,723.14 |
| Travel and Lodging | $2,911.56 |
| Food and Beverage | $2,121.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $55,604.43 | 2019-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Therasphere Y90 Glass Microspheres 10 Gbq |
| Angiodynamics, INC. | $12,891.66 | 2023-2025 | Solero, Alphavac, Solero |
| Bard Peripheral Vascular, INC. | $241.24 | 2019-2020 | |
| Medtronic Vascular, INC. | $151.26 | 2019 | |
| Terumo Medical Corporation | $129.16 | 2023-2025 | Progreat, Azur Cx Detachable, Glidewire |
| Cardiovascular Systems INC. | $87.74 | 2022 | |
| Sirtex Medical INC | $54.38 | 2020-2023 | Sir-Spheres Microspheres |
| Cook Medical LLC | $21.01 | 2025 | Tornado |
| Argon Medical Devices, INC. | $19.26 | 2025 | Clot Management |
| Penumbra, INC. | $17.41 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Savin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.